Welcome! If you have a coupon code, click here to apply it. Apply
stock
Gilead Sciences Inc
NASDAQ | GILD
105.91
USD
0.00 ( 0.00%)
AT CLOSE (AS OF Jun 25, 2025)
$133B
MARKET CAP
22.52
P/E Ratio
4.76
EPS
$118
52 Week High
$64
52 Week Low
LIFE SCIENCES
Sector
GILD Chart
Recent Chart
Price Action
1D
Candles
Trade Smarter
Automate your trading workflow with powerful tools — built for serious traders.
GILD Technicals
GILD Earnings
Yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $23B |
| Total Revenue | $29B |
| Cost Of Revenue | $6.3B |
| Costof Goods And Services Sold | $6.3B |
| Operating Income | $1.7B |
| Selling General And Administrative | $2.6B |
| Research And Development | $5.9B |
| Operating Expenses | $21B |
| Investment Income Net | - |
| Net Interest Income | -$696M |
| Interest Income | $281M |
| Interest Expense | $977M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $2.8B |
| Income Before Tax | $690M |
| Income Tax Expense | $211M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $479M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $1.7B |
| Ebitda | $4.4B |
| Net Income | $480M |
Revenue & Profitability
Earnings Performance
GILD Financials
yearly Balance Sheet (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Total Assets | $59B |
| Total Current Assets | $19B |
| Cash And Cash Equivalents At Carrying Value | $10B |
| Cash And Short Term Investments | $10B |
| Inventory | $1.7B |
| Current Net Receivables | $4.4B |
| Total Non Current Assets | $40B |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $20B |
| Intangible Assets Excluding Goodwill | $20B |
| Goodwill | $8.3B |
| Investments | - |
| Long Term Investments | $0 |
| Short Term Investments | $1.6B |
| Other Current Assets | $1.5B |
| Other Non Current Assets | - |
| Total Liabilities | $40B |
| Total Current Liabilities | $12B |
| Current Accounts Payable | $833M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $1.8B |
| Total Non Current Liabilities | $28B |
| Capital Lease Obligations | - |
| Long Term Debt | $25B |
| Current Long Term Debt | $1.8B |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $27B |
| Other Current Liabilities | $8.5B |
| Other Non Current Liabilities | $1.3B |
| Total Shareholder Equity | $19B |
| Treasury Stock | - |
| Retained Earnings | $11B |
| Common Stock | $1M |
| Common Stock Shares Outstanding | $1.3B |
yearly Cash Flow (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Operating Cashflow | $11B |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $2.8B |
| Capital Expenditures | $523M |
| Change In Receivables | - |
| Change In Inventory | -$426M |
| Profit Loss | - |
| Cashflow From Investment | - |
| Cashflow From Financing | -$3.4B |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | $3.9B |
| Dividend Payout Common Stock | $3.9B |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | -$1.2B |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $480M |
yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $23B |
| Total Revenue | $29B |
| Cost Of Revenue | $6.3B |
| Costof Goods And Services Sold | $6.3B |
| Operating Income | $1.7B |
| Selling General And Administrative | $2.6B |
| Research And Development | $5.9B |
| Operating Expenses | $21B |
| Investment Income Net | - |
| Net Interest Income | -$696M |
| Interest Income | $281M |
| Interest Expense | $977M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $2.8B |
| Income Before Tax | $690M |
| Income Tax Expense | $211M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $479M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $1.7B |
| Ebitda | $4.4B |
| Net Income | $480M |
Dividends
| Field | Value |
|---|---|
| Ex Dividend Date | 2025-06-13 |
| Declaration Date | 2025-04-22 |
| Record Date | 2025-06-13 |
| Payment Date | 2025-06-27 |
| Amount | 0.79 |
GILD News
GILD Profile
Gilead Sciences Inc Profile
Sector: LIFE SCIENCES
Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.
PSTV 75.94%
$0.329
ICU 18.49%
$0.4261
GNLN -19.10%
$0.0072
HCTI -7.88%
$0.0304
NVDA 4.27%
$154.215
QS 32.47%
$5.7358
DNN -2.22%
$1.76
TSLA -3.85%
$327.362
LCID -1.38%
$2.14
VOR 51.52%
$0.482
SRFM -25.14%
$2.695
SONM 11.61%
$1.25
SMCI 8.73%
$46.58
AXDX -61.36%
$0.034
VHAI -25.00%
$0.0004
F -2.24%
$10.49
BP 1.51%
$30.28
SAFX
36.89%
$2.3409
AMD 3.23%
$142.9007
ABEV -2.92%
$2.33
SOFI 1.20%
$16.0399
LYT -16.78%
$0.0982
BB 13.39%
$4.91
HIMS -1.79%
$42.18
JWN 0.08%
$24.66
BLNE -6.37%
$1.3296
INTC -1.22%
$22.275
PLTR -0.91%
$141.9227
SNAP 5.18%
$8.32
CRCL
-9.57%
$201.3488
WULF 0.39%
$3.855
BTE 0.83%
$1.825
PLUG -4.32%
$1.1099
ONDS -1.26%
$1.57
HOOD 0.74%
$82.615
QXO -6.36%
$22.015
WBD -0.28%
$10.8698
RIG -2.22%
$2.64
MARA 0.50%
$14.955
DFS -0.21%
$200.05
NVTS -1.84%
$7.215
VALE -1.24%
$9.0954
NCNA -5.08%
$0.0859
RIOT -0.75%
$9.945
CUTR -10.19%
$0.0969
BTG 0.28%
$3.57
AAL -3.39%
$10.985
APLD -4.88%
$9.8162
ACHR -5.73%
$10.115
AAPL 0.51%
$201.3188
CAN -5.45%
$0.6141
ITUB -2.82%
$6.5982
CLSK 5.60%
$10.6019
GRAB -2.53%
$4.62
SOUN -1.75%
$9.6478
COIN 1.74%
$350.82
GOOGL 2.07%
$170.22
QBTS -2.97%
$14.5252
TMC 16.26%
$7.685
STLA 2.87%
$9.865
WLGS 5.37%
$0.051
AG 0.76%
$8.1212
NKTR 22.90%
$30.05
AFMD -34.95%
$0.1815
NAAS 13.97%
$0.8753
ULY 81.93%
$8.17
GCTK 33.66%
$8.3
IREN 4.72%
$12.085
LDTC -19.74%
$0.1525
RZLV 3.96%
$2.8901
SHEL -1.05%
$69.4
RGTI -0.46%
$11.4471
BAC 0.39%
$46.84
CIFR 0.13%
$3.855
BBD -1.16%
$2.995
AMZN -0.55%
$211.59
GNS 7.10%
$0.7465
ASTS -6.84%
$49.5792
MU -1.39%
$126.1345
PCG -1.91%
$13.89
IQ -3.37%
$1.72
NIO -0.57%
$3.48
ADIL 8.24%
$0.2482
MLGO 5.48%
$0.6119
CCL -1.14%
$25.4072
RKLB -2.42%
$32.65
KEY 1.58%
$16.75
EQX 0.60%
$5.865
GOOG 2.09%
$171.24
PBR -0.71%
$12.322
RXRX -1.92%
$5.12
HL -0.03%
$5.798
MULN -12.87%
$0.88
SBET 6.38%
$10.2762
FLG -3.64%
$10.715
PFE -0.19%
$24.265
NGD 0.21%
$4.86
IBO 15.48%
$0.97
QUBT -5.51%
$16.56
RUN -0.56%
$7.16
PSTV 75.94%
$0.329
ICU 18.49%
$0.4261
GNLN -19.10%
$0.0072
HCTI -7.88%
$0.0304
NVDA 4.27%
$154.215
QS 32.47%
$5.7358
DNN -2.22%
$1.76
TSLA -3.85%
$327.362
LCID -1.38%
$2.14
VOR 51.52%
$0.482
SRFM -25.14%
$2.695
SONM 11.61%
$1.25
SMCI 8.73%
$46.58
AXDX -61.36%
$0.034
VHAI -25.00%
$0.0004
F -2.24%
$10.49
BP 1.51%
$30.28
SAFX
36.89%
$2.3409
AMD 3.23%
$142.9007
ABEV -2.92%
$2.33
SOFI 1.20%
$16.0399
LYT -16.78%
$0.0982
BB 13.39%
$4.91
HIMS -1.79%
$42.18
JWN 0.08%
$24.66
BLNE -6.37%
$1.3296
INTC -1.22%
$22.275
PLTR -0.91%
$141.9227
SNAP 5.18%
$8.32
CRCL
-9.57%
$201.3488
WULF 0.39%
$3.855
BTE 0.83%
$1.825
PLUG -4.32%
$1.1099
ONDS -1.26%
$1.57
HOOD 0.74%
$82.615
QXO -6.36%
$22.015
WBD -0.28%
$10.8698
RIG -2.22%
$2.64
MARA 0.50%
$14.955
DFS -0.21%
$200.05
NVTS -1.84%
$7.215
VALE -1.24%
$9.0954
NCNA -5.08%
$0.0859
RIOT -0.75%
$9.945
CUTR -10.19%
$0.0969
BTG 0.28%
$3.57
AAL -3.39%
$10.985
APLD -4.88%
$9.8162
ACHR -5.73%
$10.115
AAPL 0.51%
$201.3188
CAN -5.45%
$0.6141
ITUB -2.82%
$6.5982
CLSK 5.60%
$10.6019
GRAB -2.53%
$4.62
SOUN -1.75%
$9.6478
COIN 1.74%
$350.82
GOOGL 2.07%
$170.22
QBTS -2.97%
$14.5252
TMC 16.26%
$7.685
STLA 2.87%
$9.865
WLGS 5.37%
$0.051
AG 0.76%
$8.1212
NKTR 22.90%
$30.05
AFMD -34.95%
$0.1815
NAAS 13.97%
$0.8753
ULY 81.93%
$8.17
GCTK 33.66%
$8.3
IREN 4.72%
$12.085
LDTC -19.74%
$0.1525
RZLV 3.96%
$2.8901
SHEL -1.05%
$69.4
RGTI -0.46%
$11.4471
BAC 0.39%
$46.84
CIFR 0.13%
$3.855
BBD -1.16%
$2.995
AMZN -0.55%
$211.59
GNS 7.10%
$0.7465
ASTS -6.84%
$49.5792
MU -1.39%
$126.1345
PCG -1.91%
$13.89
IQ -3.37%
$1.72
NIO -0.57%
$3.48
ADIL 8.24%
$0.2482
MLGO 5.48%
$0.6119
CCL -1.14%
$25.4072
RKLB -2.42%
$32.65
KEY 1.58%
$16.75
EQX 0.60%
$5.865
GOOG 2.09%
$171.24
PBR -0.71%
$12.322
RXRX -1.92%
$5.12
HL -0.03%
$5.798
MULN -12.87%
$0.88
SBET 6.38%
$10.2762
FLG -3.64%
$10.715
PFE -0.19%
$24.265
NGD 0.21%
$4.86
IBO 15.48%
$0.97
QUBT -5.51%
$16.56
RUN -0.56%
$7.16
Discover more tools and features to empower your trading
Explore FeaturesQuotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.